Nicholas Fabiano, MD
@ntfabiano.bsky.social
800 followers 6 following 73 posts
Writing about science
Posts Media Videos Starter Packs
ntfabiano.bsky.social
Overall, these findings demonstrate that daily VILPA may be a promising intervention for cancer prevention in populations not able or motivated to exercise in leisure time. 10/10
ntfabiano.bsky.social
The minimal dose was 3.4 minutes per day for total (HR, 0.83; 95% CI, 0.73-0.93) and 3.7 minutes for PA-related (HR, 0.72; 95% CI, 0.59-0.88) cancer incidence. 8/10
ntfabiano.bsky.social
Compared with no VILPA, the median daily VILPA duration of bouts up to 1 minute (4.5 minutes per day) was associated with an HR of 0.80 (95% CI, 0.69-0.92) for total cancer and 0.69 (95% CI, 0.55-0.86) for PA-related cancer. 7/10
ntfabiano.bsky.social
Daily VILPA duration was associated with outcomes in a near-linear manner, with steeper dose-response curves for PA-related cancer than total cancer incidence. 6/10
ntfabiano.bsky.social
The study sample comprised 22,398 participants (mean [SD] age, 62.0 [7.6] years; 10,122 [45.2%] men and 12 276 [54.8%] women; 21 509 [96.0%] White individuals). 5/10
ntfabiano.bsky.social
Vigorous physical activity (VPA) is a time-efficient way to achieve recommended physical activity (PA) for cancer prevention, although structured longer bouts of VPA (via traditional exercise) are unappealing or inaccessible to many individuals. 4/10
ntfabiano.bsky.social
Nonexercising adults, the majority of the middle-aged population, are at an increased risk of developing certain cancers. 3/10
ntfabiano.bsky.social
These findings are from a study in JAMA Oncology which aimed to evaluate the dose-response association of device-measured daily vigorous intermittent lifestyle physical activity (VILPA) with incident cancer. jamanetwork.com/journals/jam... 2/10
ntfabiano.bsky.social
Just 3 to 4 minutes of vigorous physical activity per day is associated with decreased cancer risk.

🧵1/10
ntfabiano.bsky.social
Overall, these findings highlight the need for continuous surveillance of emerging mutations in avian and bovine clade 2.3.4.4b H5N1 viruses. 9/9
ntfabiano.bsky.social
In nature, the occurrence of this single mutation could be an indicator of human pandemic risk. 8/9
ntfabiano.bsky.social
A single glutamine to leucine mutation at residue 226 of the virus hemagglutinin was sufficient to enact the change from avian to human specificity. 7/9
ntfabiano.bsky.social
Historically, this virus has caused up to 30% fatality in humans. 6/9
ntfabiano.bsky.social
As of October 2024, the CDC has reported 15 human infections worldwide with the 2.3.4.4b virus but 17 human infections with the H5 subtype in the US since 2022, including cases of the 2.3.4.4b virus from exposure to infected cows and poultry. 5/9
ntfabiano.bsky.social
In 2024, clade 2.3.4.4b virus spread widely in dairy cattle in the US, causing a few mild human cases, but retaining specificity for avian receptors. 4/9
ntfabiano.bsky.social
In 2021, a highly pathogenic influenza H5N1 clade 2.3.4.4b virus was detected in North America that is capable of infecting a diversity of avian species, marine mammals, and humans. 3/9
ntfabiano.bsky.social
These findings are from a study in Science which performed a genetic and structural analysis of the H5N1 mutations necessary to fully switch host receptor recognition. www.science.org/doi/10.1126/... 2/9
ntfabiano.bsky.social
We are one mutation away from human-to-human transmission of H5N1 (bird flu).

🧵1/9
ntfabiano.bsky.social
Overall, these results highlight the potential of targeting specific brain regions to maximize the engagement of spinal cord-projecting neurons in the recovery of neurological functions after spinal cord injury. 11/11
ntfabiano.bsky.social
A pilot clinical study showed that DBSLH immediately improved walking in two participants with incomplete SCI and, in conjunction with rehabilitation, mediated functional recovery that persisted when DBSLH was turned off. 10/11
ntfabiano.bsky.social
This discovery was translated into a deep brain stimulation therapy of the LH (DBSLH) that immediately augmented walking in mice and rats with SCI and durably increased recovery through the reorganization of residual lumbar-terminating projections from brainstem neurons. 9/11
ntfabiano.bsky.social
Specifically, it was found that glutamatergic neurons located in the LH (LHVglut2) contribute to the recovery of walking after incomplete SCI and that augmenting their activity improves walking. 8/11
ntfabiano.bsky.social
Unexpectedly, interrogation of this atlas nominated the lateral hypothalamus (LH). 7/11
ntfabiano.bsky.social
To uncover these regions, a space–time brain-wide atlas of transcriptionally active and spinal cord-projecting neurons underlying the recovery of walking after incomplete SCI was constructed. 6/11